Emergence of High Prevalence of Extended-Spectrum Beta-Lactamase and Carbapenemase Producing Acinetobacter Species and Pseudomonas aeruginosa Among Hospitalized Patients at Dessie Comprehensive Specialized Hospital, North-East Ethiopia

References

• Kaur A, Singh S. Prevalence of extended spectrum betalactamase (ESBL) and metallobetalactamase (MBL) producing Pseudomonas aeruginosa and Acinetobacter baumannii isolated from various clinical samples. J Pathog. 2018;2018:6845985.
   PubMed Web of Science ®Google Scholar
• Qureshi MA, Bhatnagar RK. Phenotypic characterization of ESBL, AmpC and MBL producers among the clinical isolates of multidrug resistant Pseudomonas aeruginosa. Int J Curr Microbiol App Sci. 2016;5(10):749–758. doi:10.20546/ijcmas.2016.510.081
   Google Scholar
• Ettu A, Oladapo B, Oduyebo O. Prevalence of carbapenemase production in Pseudomonas aeruginosa isolates causing clinical infections in Lagos University Teaching Hospital, Nigeria. African J Clin Exp Microbiol. 2021;22(4):498–503. doi:10.4314/ajcem.v22i4.10
   Google Scholar
• Codjoe FS, Donkor ES. Carbapenem resistance: a review. Med Sci. 2018;6(1):1. doi:10.3390/medsci6010001
   Google Scholar
• Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18(5):263–272. doi:10.1016/j.molmed.2012.03.003
   PubMed Web of Science ®Google Scholar
• Kateete DP, Nakanjako R, Namugenyi J, Erume J, Joloba ML, Najjuka CF. Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009). Springerplus. 2016;5(1):1–11. doi:10.1186/s40064-016-2986-7
   Google Scholar
• Kateete DP, Nakanjako R, Okee M, Joloba ML, Najjuka CF. Genotypic diversity among multidrug resistant Pseudomonas aeruginosa and Acinetobacter species at Mulago Hospital in Kampala, Uganda. BMC Res Notes. 2017;10(1):1–10. doi:10.1186/s13104-017-2612-y
   Google Scholar
• Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: epidemiology and resistance features. Saudi J Biol Sci. 2018;25(3):586–596. doi:10.1016/j.sjbs.2016.02.009
   PubMed Web of Science ®Google Scholar
• Nørgaard SM, Jensen CS, Aalestrup J, Vandenbroucke-Grauls CM, de Boer MG, Pedersen AB. Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review. Antimicrob Resist Infect Control. 2019;8(1):1–13. doi:10.1186/s13756-019-0624-1
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Pseudomonas Aeruginosa in Healthcare Settings. Centers for Disease Control and Prevention; 2019.
   Google Scholar
• Shrivastava SR, Shrivastava PS, Ramasamy J. World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. J Med Soc. 2018;32(1):76. doi:10.4103/jms.jms_25_17
   Google Scholar
• Shrivastava SR, Shrivastava PS. Emergence of antibiotic resistance: a global public health and a political priority. Hamdan Med J. 2019;12(4):236. doi:10.4103/HMJ.HMJ_93_18
   Google Scholar
• Alebel M, Mekonnen F, Mulu W. Extended-spectrum β-lactamase and carbapenemase producing gram-negative bacilli infections among patients in intensive care units of Felege Hiwot Referral Hospital: a prospective cross-sectional study. Infect Drug Resist. 2021;14:391. doi:10.2147/IDR.S292246
   Web of Science ®Google Scholar
• Plachouras D, Kärki T, Hansen S, et al. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017. Eurosurveillance. 2018;23(46):1800393. doi:10.2807/1560-7917.ES.23.46.1800393
   Web of Science ®Google Scholar
• Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology E-Book. Elsevier Health Sciences; 2020.
   Google Scholar
• Levine NS, Lindberg RB, Mason JAD, Pruitt JBA. The quantitative swab culture and smear: a quick, simple method for determining the number of viable aerobic bacteria on open wounds. J Trauma. 1976;16(2):89–94. doi:10.1097/00005373-197602000-00002
   PubMedGoogle Scholar
• Cheesbrough M. District Laboratory Practice in Tropical Countries, Part 2. Cambridge University Press; 2005.
   Google Scholar
• Mahmood T, Yang P-C. Western blot: technique, theory, and trouble shooting. N Am J Med Sci. 2012;4(9):429. doi:10.4103/1947-2714.100998
   PubMedGoogle Scholar
• Levinson W. Review of Medical Microbiology and Immunology. McGraw-Hill Education; 2014.
   Google Scholar
• Weinstein MP, Lewis JS. The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. J Clin Microbiol. 2020;58(3):e01864–19. doi:10.1128/JCM.01864-19
   PubMed Web of Science ®Google Scholar
• Kunz AN, Brook I. Emerging resistant gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy. 2010;56(6):492–500. doi:10.1159/000321018
   PubMed Web of Science ®Google Scholar
• Bitew A. High prevalence of multi-drug resistance and extended spectrum beta lactamase production in non-fermenting gram-negative bacilli in Ethiopia. Infect Dis Res Treat. 2019;12:1178633719884951.
   Google Scholar
• Tolera M, Abate D, Dheresa M, Marami D. Bacterial nosocomial infections and antimicrobial susceptibility pattern among patients admitted at Hiwot Fana Specialized University Hospital, Eastern Ethiopia. Adv Med. 2018;2018:89–94.
   Google Scholar
• Motbainor H, Bereded F, Mulu W. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felege Hiwot Referral Hospital, Northwest Ethiopia: a cross-sectional study. BMC Infect Dis. 2020;20(1):1–11. doi:10.1186/s12879-020-4811-8
   Web of Science ®Google Scholar
• De Francesco MA, Ravizzola G, Peroni L, Bonfanti C, Manca N. Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital. J Infect Public Health. 2013;6(3):179–185. doi:10.1016/j.jiph.2012.11.006
   PubMed Web of Science ®Google Scholar
• Agyepong N, Govinden U, Owusu-Ofori A, Essack SY. Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana. Antimicrob Resist Infect Control. 2018;7(1):1–8. doi:10.1186/s13756-018-0324-2
   PubMed Web of Science ®Google Scholar
• Sharif MR, Soltani B, Moravveji A, Erami M, Soltani N. Prevalence and risk factors associated with extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae isolates in hospitalized patients in Kashan (Iran). Electron Phys. 2016;8(3):2081. doi:10.19082/2081
   Google Scholar
• Shaikh S, Fatima J, Shakil S, Rizvi SMD, Kamal MA. Risk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitals. Saudi J Biol Sci. 2015;22(1):37–41. doi:10.1016/j.sjbs.2014.05.006
   PubMed Web of Science ®Google Scholar
• Legese MH, Weldearegay GM, Asrat D. Extended-spectrum beta-lactamase-and carbapenemase-producing Enterobacteriaceae among Ethiopian children. Infect Drug Resist. 2017;10:27. doi:10.2147/IDR.S127177
   PubMed Web of Science ®Google Scholar
• Ouedraogo A-S, Sanou M, Kissou A, et al. High prevalence of extended-spectrum ß-lactamase producing Enterobacteriaceae among clinical isolates in Burkina Faso. BMC Infect Dis. 2016;16(1):1–9. doi:10.1186/s12879-016-1655-3
   Web of Science ®Google Scholar
• Amladi AU, Sudarsanam TD, Kandasamy S, Kekre N, Veeraraghavan B, Sahni RD. Evaluation of CHROMagar™ TMmSuperCARBA™ as a phenotypic test for detection of carbapenemase producing organisms. J Clin Diagn Res. 2019;13(9):19–22.
   Google Scholar
• Beyene D, Bitew A, Fantew S, Mihret A, Evans M. Multidrug-resistant profile and prevalence of extended spectrum β-lactamase and carbapenemase production in fermentative gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia. PLoS One. 2019;14(9):e0222911. doi:10.1371/journal.pone.0222911
   PubMed Web of Science ®Google Scholar
• Chang -Y-Y, Chuang Y-C, Siu LK, et al. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect. 2015;48(2):219–225. doi:10.1016/j.jmii.2014.05.010
   PubMedGoogle Scholar
• Saharman YR, Lestari DC. Phenotype characterization of Beta-lactamase producing Enterobacteriaceae in the intensive care unit (ICU) of Cipto Mangunkusumo hospital in 2011. Acta Medica Indonesiana. 2016;45(1):11–16
   Google Scholar
• Kayastha K, Dhungel B, Karki S, et al. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in pediatric patients visiting International Friendship Children’s Hospital, Kathmandu, Nepal. Infect Dis Res Treat. 2020;13:1178633720909798.
   Google Scholar
• Zaha DC, Kiss R, Hegedűs C, et al. Recent advances in investigation, prevention, and management of healthcare-associated infections (HAIs): resistant multidrug strain colonization and its risk factors in an intensive care unit of a University Hospital. Biomed Res Int. 2019;2019:2510875.
   Web of Science ®Google Scholar
• Kano C. Carbapenem-Resistant Enterobacteriaceae (CRE) in intensive care units and surgical wards of hospitals with no history of carbapenem usage in Kano, North West Nigeria. Niger J Microbiol. 2015;27(1):2612–2618.
   Google Scholar
• Oberoi L, Singh N, Sharma P, Aggarwal A. ESBL, MBL and Ampc β lactamases producing superbugs–havoc in the Intensive Care Units of Punjab India. J Clin Diagn Res. 2013;7(1):70. doi:10.7860/JCDR/2012/5016.2673
   PubMedGoogle Scholar
• Ssekatawa K, Byarugaba DK, Wampande E, Ejobi F. A systematic review: the current status of carbapenem resistance in East Africa. BMC Res Notes. 2018;11(1):1–9. doi:10.1186/s13104-018-3738-2
   PubMedGoogle Scholar
• Hecini-Hannachi A, Bentchouala C, Lezzar A, Laouar H, Benlabed K, Smati F. Multidrug-resistant bacteria isolated from patients hospitalized in intensive care unit in University Hospital of Constantine, Algeria (2011–2015). Afr J Microbiol Res. 2016;10(33):1328–1336. doi:10.5897/AJMR2016.8257
   Google Scholar
• Liao C-H, Lee N-Y, Tang H-J, et al. Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016. Infect Drug Resist. 2019;12:545. doi:10.2147/IDR.S193638
   Web of Science ®Google Scholar
• Mohajeri P, Sharbati S, Farahani A, Rezaei Z. Evaluate the frequency distribution of nonadhesive virulence factors in carbapenemase-producing Acinetobacter baumannii isolated from clinical samples in Kermanshah. J Nat Sci Biol Med. 2016;7(1):58. doi:10.4103/0976-9668.175071
   Google Scholar
• Meletis G, Exindari M, Vavatsi N, Sofianou D, Diza E. Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa. Hippokratia. 2012;16(4):303.
   PubMed Web of Science ®Google Scholar
• Exner M, Bhattacharya S, Christiansen B, et al. Antibiotic resistance: what is so special about multidrug-resistant Gram-negative bacteria? GMS Hyg Infect Control. 2017;12:Doc05.
   PubMed Web of Science ®Google Scholar
• Tran GM, Ho-le TP, Ha DT, et al. Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam. BMC Infect Dis. 2017;17(1):1–7. doi:10.1186/s12879-017-2529-z
   Web of Science ®Google Scholar
• Musyoki VM, Masika MM, Mutai W, Wilfred G, Kuria A, Muthini F. Antimicrobial susceptibility pattern of Acinetobacter isolates from patients in Kenyatta National Hospital, Nairobi, Kenya. Pan Afr Med J. 2019;33:146.
   Web of Science ®Google Scholar
• Carrillo JV, Uzcategui RP, Fermín LR, Zambrano RA, Fermin LR. Caracterización química y actividad antibacteriana del aceite esencial de Mangifera indica L. [Chemical characterization and antibacterial activity of the essential oil of Mangifers indica L in three regions of Venezuela]Revista Colombiana de Química. 2019;48(3):13–18. Spanish.
   Web of Science ®Google Scholar
• Ranjbar R, Farahani A. Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Acinetobacter baumannii isolated from burn wound infections in Iran. Antimicrob Resist Infect Control. 2019;8(1):1–11. doi:10.1186/s13756-019-0612-5
   Web of Science ®Google Scholar
• Kaur T, Putatunda C, Oberoi A, Vyas A, Kumar G. Prevalence and drug resistance in Acinetobacter sp. isolated from intensive care units patients in Punjab, India; 2018.
   Google Scholar
• Mohajeri P, Farahani A, Feizabadi M, Norozi B. Clonal evolution multi-drug resistant Acinetobacter baumannii by pulsed-field gel electrophoresis. Indian J Med Microbiol. 2015;33(1):87–91. doi:10.4103/0255-0857.148390
   Web of Science ®Google Scholar
• Diriba K, Awulachew E, Gemede A, Anja A. The magnitude of extended-spectrum beta-lactamase-producing Enterobacteriaceae from clinical samples in Ethiopia: a systematic review and meta-analysis. Access Microbiol. 2021;3(3). doi:10.1099/acmi.0.000195
   Google Scholar
• Queenan AM, Pillar CM, Deane J, et al. Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL surveillance 2010. Diagn Microbiol Infect Dis. 2012;73(3):267–270. doi:10.1016/j.diagmicrobio.2012.04.002
   PubMed Web of Science ®Google Scholar
• Rebic V, Masic N, Teskeredzic S, Aljicevic M, Abduzaimovic A, Rebic D. The importance of Acinetobacter species in the hospital environment. Med Arch. 2018;72(5):325. doi:10.5455/medarh.2018.72.330-334
   Google Scholar
• Dash M, Padhi S, Pattnaik S, Mohanty I, Misra P. Frequency, risk factors, and antibiogram of Acinetobacter species isolated from various clinical samples in a tertiary care hospital in Odisha, India. Avicenna J Med. 2013;3(4):97. doi:10.4103/2231-0770.120501
   Google Scholar
• Al-Mously N. Acinetobacter baumannii bloodstream infections in a tertiary hospital: antimicrobial resistance surveillance. Int J Infect Control. 2013;9(2). doi:10.3396/ijic.v9i2.012.13
   Google Scholar
• Mohajeri P, Farahani A, Mehrabzadeh RS. Molecular characterization of multidrug resistant strains of Acinetobacter baumannii isolated from intensive care units in west of Iran. J Clin Diagn Res. 2017;11(2):DC20. doi:10.7860/JCDR/2017/21156.9397
   Web of Science ®Google Scholar
• Tsao L-H, Hsin C-Y, Liu H-Y, Chuang H-C, Chen L-Y, Lee Y-J. Risk factors for healthcare-associated infection caused by carbapenem-resistant Pseudomonas aeruginosa. J Microbiol Immunol Infect. 2018;51(3):359–366. doi:10.1016/j.jmii.2017.08.015
   Google Scholar
• Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist. 2018;11:1249. doi:10.2147/IDR.S166750
   PubMed Web of Science ®Google Scholar